Oramed to Raise $15,800,000 in Registered Direct Offering

[Northerner]

Oramed Pharmaceuticals Inc. (nasdaqcm:ORMP), a developer of oral drug delivery systems, today announced that it has entered into definitive agreements with investors to purchase an aggregate of 1,580,000 shares of common stock at a price of $10.00 per share in a registered direct offering. The offering is expected to close on or about December 31, 2013, subject to the satisfaction of customary closing conditions.

http://www.marketwatch.com/story/oramed-to-raise-15800000-in-registered-direct-offering-2013-12-24